Understanding the Regulatory Pathways Used to Develop, Evaluate, Authorize, and Approve New Drugs and Vaccines in the United States
Overview
Overview
Journal
J Pediatric Infect Dis Soc
Publisher
Oxford University Press
Specialties
Infectious Diseases
Pediatrics
Pediatrics
Date
2024 Jul 12
PMID
38995086
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The United States (U.S.) Food and Drug Administration (FDA) oversees the safety and quality of drugs and vaccines that are used in the U.S. Administration of the FDA falls under the jurisdiction of the U.S. Department of Health and Human Services (HHS). The regulatory oversight of the FDA is complex and comprehensive, requiring the various roles and responsibilities to be divided across six main centers. The activities of two of these centers, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) are the primary focus of this review.